Therapeutic Biliary Endoscopy

Some steps of progress have been seen in the area of biliary therapeutic endoscopy, in the understanding and management of primary sclerosing cholangitis, problems relating to liver transplantation, malignant biliary strictures, complications after endoscopic retrograde cholangiopancreatography, sphincter of Oddi dysfunction, and tissue sampling. The benefits (or lack thereof) of preoperative biliary drainage in the setting of malignant obstructive jaundice have received an extensive review.

References

• 1 Sandler R S, Everhart J E, Donowitz M. et al . The burden of selected digestive diseases in the United States.  Gastroenterology. 2002;  122 1500-1511
• 2 Lang L. Panel issues ERCP recommendations.  Gastroenterology. 2002;  122 601-602
• 3 Bergman J J, Burgemeister L, Bruno M J. et al . Long-term follow-up after biliary stent placement for postoperative bile duct stenosis.  Gastrointest Endosc. 2001;  54 154-161
• 4 Costamagna G, Pandolfi M, Mutignani M. et al . Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents.  Gastrointest Endosc. 2001;  54 162-168
• 5 Draganov P, Hoffman B, Marsh W. et al . Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents.  Gastrointest Endosc. 2002;  55 680-686
• 6 Singh N, Sherman S, Phillips S D. et al . Outcome of endoscopic biliary stenting in chronic pancreatitis-induced common bile duct strictures.  Gastrointest Endosc. 2001;  53 AB94
• 7 Baluyut A R, Sherman S, Lehman G A. et al . Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.  Gastrointest Endosc. 2001;  53 308-312
• 8 Stiehl A, Rudolph G, Kloters-Plachky P. et al . Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.  J Hepatol. 2002;  36 151-156
• 9 Linder S, Soderlund C. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.  Hepatogastroenterology. 2001;  48 387-392
• 10 Kaya M, de Groen P C, Angulo P. et al . Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.  Am J Gastroenterol. 2001;  96 1164-1169
• 11 Siqueira E, Schoen R E, Silverman W. et al . Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.  Gastrointest Endosc. 2002;  56 40-47
• 12 Rerknimitr R, Sherman S, Fogel E L. et al . Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy.  Gastrointest Endosc. 2002;  55 224-231
• 13 Morelli J, Mulcahy H E, Willner I R. et al . Endoscopic treatment of post-liver transplantation biliary leaks with stent placement across the leak site.  Gastrointest Endosc. 2001;  54 471-475
• 14 DeBellis M, Fogel E L, Sherman S. et al . Frequency of laparoscopic cholecystectomy injuries detected at ERCP: eight-year experience at a tertiary referral center.  Gastrointest Endosc. 2002;  55 AB186
• 15 Chaudhary A, Manisegran M, Chandra A. et al . How do bile duct injuries sustained during laparoscopic cholecystectomy differ from those during open cholecystectomy?.  J Laparoendosc Adv Surg Tech A. 2001;  11 187-191
• 16 Arnold J C, Benz C, Martin W R. et al . Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study.  Endoscopy. 2001;  33 563-567
• 17 Komatsu Y, Fujita N, Maguchi H. et al . Prospective randomized controlled trial of endoscopic sphincterotomy compared with endoscopic papillary balloon dilatation for bile duct stones: short-term outcome and biliary symptoms in 6 months.  Gastrointest Endosc. 2002;  55 AB169
• 18 Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.  Gastrointest Endosc. 2001;  54 209-213
• 19 Moon J H, Cho Y D, Ryu C B. et al . The role of percutaneous transhepatic papillary balloon dilation in percutaneous choledochoscopic lithotomy.  Gastrointest Endosc. 2001;  54 232-236
• 20 Yasuda I, Tomita E, Enya M. et al . Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?.  Gut. 2001;  49 686-691
• 21 Sugiyama M, Atomi Y. Medium-term effects of endoscopic papillary balloon dilation on gallbladder motility.  Gastrointest Endosc. 2001;  54 459-463
• 22 Huibregtse K. Endoscopic balloon dilation for removal of bile duct stones: special indications only.  Endoscopy. 2001;  33 620-622
• 23 Sewnath M E, Karsten T M, Prins M H. et al . A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.  Ann Surg. 2002;  236 17-27
• 24 Arguedas M R, Heudebert G H. et al . Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.  Am J Gastroenterol. 2002;  97 898-904
• 25 Ferlitsch A, Oesterreicher C, Dumonceau J M. et al . Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluation.  Endoscopy. 2001;  33 645-650
• 26 Kim H S, Lee D K, Kim H G. et al . Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study.  Gastrointest Endosc. 2002;  55 359-365
• 27 Isayama H, Komatsu Y, Tsujino T. et al . Polyurethane-covered metal stent for management of distal malignant biliary obstruction.  Gastrointest Endosc. 2002;  55 366-370
• 28 Weaver S A, Stacey B S, Hayward S J. et al . Endoscopic palliation and survival in malignant biliary obstruction.  Dig Dis Sci. 2001;  46 2147-2153
• 29 Halm U, Schiefke , Fleig W E. et al . Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial.  Endoscopy. 2001;  33 491-494
• 30 Weickert U, Venzke T, Konig J. et al . Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients.  Endoscopy. 2001;  33 786-790
• 31 Catalano M F, Geenen J E, Lehman G A. et al . “Tannenbaum” Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture.  Gastrointest Endosc. 2002;  55 354-358
• 32 Ortner M E, Giesse A, Caca K. et al . Photodynamic therapy of non-resectable cholangiocarcinoma: a randomized prospective study - first results.  Gastrointest Endosc. 2001;  53 AB85
• 33 Zoepf T, Jakobs R, Arnold J C. et al . Photodynamic therapy for palliation of nonresectable bile duct cancer: preliminary results with a new diode laser system.  Am J Gastroenterol. 2001;  96 2093-2097
• 34 Zoepf T, Jakobs R, Rosenbaum A. et al . Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer.  Gastrointest Endosc. 2001;  54 763-766
• 35 Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis.  Gastrointest Endosc. 2001;  54 435-440
• 36 Devière J, Le M oine, van Laethem J L. et al . Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.  Gastroenterology. 2001;  120 498-505
• 37 McHenry L, Monroe P, Duckworth F. et al . A randomized, double-blind pilot study of the efficacy of interleukin-10 (IL-10) in the prevention of post-ERCP pancreatitis.  Am J Gastroenterol. 2001;  96 S61-S62
• 38 Epstein M S, DeHaemer T, Praschak P M. et al . Double-blind, placebo-controlled pilot study of the safety and activity of interleukin-10 (RHuIL-10) in the prevention of acute pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP).  Am J Gastroenterol. 2001;  96 S85-S86
• 39 Manolakopoulos S, Avgerinos A, Vlachogiannakos J. et al . Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.  Gastrointest Endosc. 2002;  55 470-475
• 40 Freeman M L, Cass O W, Dailey J. Dilation of high-grade pancreatic and biliary ductal strictures with small-caliber angioplasty balloons.  Gastrointest Endosc. 2001;  54 89-92
• 41 Silverman W B, Thompson R A. Management of asymptomatically/minimally symptomatic post-ERCP serum liver test elevations: first do no harm.  Dig Dis Sci. 2002;  47 1498-1501
• 42 Enns R, Eloubeidi M A, Mergener K. et al . ERCP-related perforations: risk factors and management.  Endoscopy. 2002;  34 293-298
• 43 Eisen G M, Baron T H, Dominitz J A. et al . Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures.  Gastrointest Endosc. 2002;  55 775-779
• 44 Pineau B C, Knapple W L, Spicer K M. et al . Cholecystokinin-stimulated mebrofenin (^99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility.  Am J Gastroenterol. 2001;  96 3106-3109
• 45 Thomas P D, Turner J G, Dobbs B R. et al . Use of (99m) Tc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure.  Gut. 2000;  46 838-841
• 46 Cicala M, Habib F I, Vavassori P. et al . Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy.  Gut. 2002;  50 665-668
• 47 Rosenblatt M L, Catalano M F, Alcocer E, Geenen J E. Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction.  Gastrointest Endosc. 2001;  54 697-704
• 48 Hogan W J. Hepatobiliary scintigraphy as the diagnostic test for sphincter of Oddi dysfunction: pan the scan?.  Am J Gastroenterol. 2002;  97 1288-1291
• 49 Quallich L G, Stern M A, Rich M. et al . Bile duct crystals do not contribute to sphincter of Oddi dysfunction.  Gastrointest Endosc. 2002;  55 163-166
• 50 di Francesco V, Mariani A, Angelini G. et al . Effects of gabexate mesilate, a protease inhibitor, on human sphincter of Oddi motility.  Dig Dis Sci. 2002;  47 741-745
• 51 Fazel A, Burton F R. A controlled study of the effect of midazolam on abnormal sphincter of Oddi motility.  Gastrointest Endosc. 2002;  55 637-640
• 52 Fogel E L, Eversman D, Jamidar P. et al . Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.  Endoscopy. 2002;  34 280-285
• 53 Kaufman D, Widlus D, Lazinger M. et al . Diagnostic accuracy of Simpson atherectomy catheter biopsy in detecting pancreaticobiliary malignancy.  Am J Gastroenterol. 2001;  96 1054-1058
• 54 Mazzaglia P, Howell D A, Sheth S G. et al . Clinical value of tissue sampling at ERCP.  Gastrointest Endosc. 2002;  55 AB170
• 55 Farrell R J, Jain A K, Brandwein S L. et al . The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures.  Gastrointest Endosc. 2001;  54 587-594
• 56 Heiss F W, Cimis R S, MacMillan, Jr F P. Biliary sphincter scissor for pre-cut access: preliminary experience.  Gastrointest Endosc. 2002;  55 719-722
• 57 Feitoza A B, Baron T H. Endoscopy and ERCP in the setting of previous upper GI tract surgery, 1: reconstruction without alteration of pancreaticobiliary anatomy.  Gastrointest Endosc. 2001;  54 743-749
• 58 Freeman M L, DiSario J A, Nelson D B. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.  Gastrointest Endosc. 2001;  54 425-434